Angiostatin effects on endothelial cells mediated by ceramide and RhoA

Area of Science:

• Endocrinology
• Cell Biology
• Biochemistry

Background:

• Angiostatin, a plasminogen cleavage product, exhibits anti-angiogenic properties.
• Ceramide, a lipid signaling molecule, is implicated in endothelial cell function and apoptosis.
• The precise mechanisms by which angiostatin exerts its effects on endothelial cells remain under investigation.

Purpose of the Study:

• To investigate if ceramide mediates the anti-angiogenic effects of angiostatin on endothelial cells.
• To elucidate the signaling pathways involved in angiostatin-induced endothelial cell responses.
• To explore the role of free radicals in angiostatin's mechanism of action.

Main Methods:

• Treatment of human endothelial cells with angiostatin and ceramide.
• Measurement of ceramide levels and assessment of cell viability.
• DNA array expression analysis to identify gene expression changes.
• Analysis of RhoA activation and actin cytoskeleton organization.
• Evaluation of the effects of N-acetylcysteine, an antioxidant.

Main Results:

• Angiostatin induced a transient increase in ceramide levels in endothelial cells.
• This ceramide increase correlated with actin stress fiber reorganization, cell detachment, and death.
• Ceramide treatment led to the induction of genes involved in cytoskeleton organization.
• Both angiostatin and ceramide activated RhoA, a key regulator of the cytoskeleton.
• N-acetylcysteine treatment abrogated the morphological changes and cytotoxic effects induced by angiostatin and ceramide.

Conclusions:

• Angiostatin's anti-angiogenic effects on endothelial cells are, in part, mediated by ceramide.
• A signaling cascade involving transient ceramide increase, RhoA activation, and free radical production is proposed.
• These findings provide insights into the molecular mechanisms underlying angiostatin's anti-angiogenic activity and suggest potential therapeutic targets.